{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:44:45Z","timestamp":1793853885657,"version":"4.6.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12889-017-4414-5","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T14:10:37Z","timestamp":1495462237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa"],"prefix":"10.1186","volume":"17","author":[{"given":"Adam","family":"Silumbwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Mumba","family":"Zulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikabasa","family":"Halwindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choolwe","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Zgambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Dambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mumbi","family":"Chola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gershom","family":"Chongwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Michelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"key":"4414_CR1","volume-title":"Global programme to eliminate lymphatic filariasis: progress report","author":"WHO","year":"2015","unstructured":"WHO. Global programme to eliminate lymphatic filariasis: progress report. 2015; Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs102\/en\/ . Accessed 15 Nov 2016."},{"issue":"11","key":"4414_CR2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003319","volume":"8","author":"K Ramaiah","year":"2014","unstructured":"Ramaiah K, Ottesen EA. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis. 2014;8(11):e3319.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"4414_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-9957-4-1","volume":"4","author":"TG Ton","year":"2015","unstructured":"Ton TG, Mackenzie C, Molyneux DH. The burden of mental health in lymphatic filariasis. Infect Dis Poverty. 2015;4(1):1.","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"4414_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000128","volume":"1","author":"M Perera","year":"2007","unstructured":"Perera M, et al. Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis. PLoS Negl Trop Dis. 2007;1(2):e128.","journal-title":"PLoS Negl Trop Dis"},{"key":"4414_CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","volume":"61","author":"EA Ottesen","year":"2006","unstructured":"Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol. 2006;61:395\u2013441.","journal-title":"Adv Parasitol"},{"key":"4414_CR6","volume-title":"Lymphatic filariasis: fact sheet","author":"WHO","year":"2016","unstructured":"WHO. Lymphatic filariasis: fact sheet. 2016; Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs102\/en\/ ."},{"issue":"3","key":"4414_CR7","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2214-109X(15)00292-2","volume":"4","author":"MJ Bockarie","year":"2016","unstructured":"Bockarie MJ, Rebollo MP. Reducing the population requiring interventions against lymphatic filariasis in Africa. Lancet Glob Health. 2016;4(3):e154\u20135.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"4414_CR8","volume":"3","author":"PJ Hotez","year":"2009","unstructured":"Hotez PJ, Kamath A. Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis. 2009;3(8):e412.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9710","key":"4414_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)61422-7","volume":"375","author":"L Conteh","year":"2010","unstructured":"Conteh L, Engels T, Molyneux DH. Socioeconomic aspects of neglected tropical diseases. Lancet. 2010;375(9710):239\u201347.","journal-title":"Lancet"},{"key":"4414_CR10","volume-title":"Global programme to eliminate lymphatic filariasis: annual report on lymphatic filariasis 2001","author":"Organization, W.H","year":"2002","unstructured":"Organization, W.H., Global programme to eliminate lymphatic filariasis: annual report on lymphatic filariasis 2001. 2002."},{"issue":"9","key":"4414_CR11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","volume":"5","author":"EA Ottesen","year":"2000","unstructured":"Ottesen EA. Editorial: the global programme to eliminate lymphatic filariasis. Tropical Med Int Health. 2000;5(9):591\u20134.","journal-title":"Tropical Med Int Health"},{"issue":"1623","key":"4414_CR12","doi-asserted-by":"crossref","first-page":"20120144","DOI":"10.1098\/rstb.2012.0144","volume":"368","author":"MJ Bockarie","year":"2013","unstructured":"Bockarie MJ, et al. Preventive chemotherapy as a strategy for elimination of neglected tropical parasitic diseases: endgame challenges. Philos Trans R Soc Lond B. 2013;368(1623):20120144.","journal-title":"Philos Trans R Soc Lond B"},{"issue":"4","key":"4414_CR13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.2008.79.480","volume":"79","author":"D Kyelem","year":"2008","unstructured":"Kyelem D, et al. Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. AmJTrop Med Hyg. 2008;79(4):480\u20134.","journal-title":"AmJTrop Med Hyg"},{"issue":"6","key":"4414_CR14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","volume":"9","author":"B Babu","year":"2004","unstructured":"Babu B, Kar SK. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. Tropical Med Int Health. 2004;9(6):702\u20139.","journal-title":"Tropical Med Int Health"},{"issue":"5","key":"4414_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trstmh.2006.09.002","volume":"101","author":"S Gunawardena","year":"2007","unstructured":"Gunawardena S, et al. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka. Trans R Soc Trop Med Hyg. 2007;101(5):445\u201353.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"4414_CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0035-9203(89)90343-X","volume":"83","author":"F Partono","year":"1989","unstructured":"Partono F, Maizels RM, Purnomo. Towards a filariasis-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia. Trans R Soc Trop Med Hyg. 1989;83(6):821\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"4414_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1179\/136485905X29666","volume":"99","author":"P Vanamail","year":"2005","unstructured":"Vanamail P, et al. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol. 2005;99(3):237\u201342.","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"4414_CR18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000728","volume":"4","author":"PT Cantey","year":"2010","unstructured":"Cantey PT, et al. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis. 2010;4(6):e728.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"4414_CR19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1179\/000349804X3135","volume":"98","author":"E Mathieu","year":"2004","unstructured":"Mathieu E, et al. Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Ann Trop Med Parasitol. 2004;98(7):703\u201314.","journal-title":"Ann Trop Med Parasitol"},{"issue":"4","key":"4414_CR20","first-page":"313","volume":"45","author":"C Lahariya","year":"2008","unstructured":"Lahariya C, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Dis. 2008;45(4):313\u201320.","journal-title":"J Vector Borne Dis"},{"issue":"10","key":"4414_CR21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109316","volume":"9","author":"WJ Kisoka","year":"2014","unstructured":"Kisoka WJ, et al. Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania. PLoS One. 2014;9(10):e109316.","journal-title":"PLoS One"},{"key":"4414_CR22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1756-3305-3-120","volume":"3","author":"MH Hodges","year":"2010","unstructured":"Hodges MH, et al. High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone. Parasit Vectors. 2010;3:120.","journal-title":"Parasit Vectors"},{"key":"4414_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1756-3305-5-232","volume":"5","author":"MH Hodges","year":"2012","unstructured":"Hodges MH, et al. Maintaining effective mass drug administration for lymphatic filariasis through in-process monitoring in Sierra Leone. Parasit Vectors. 2012;5:232.","journal-title":"Parasit Vectors"},{"issue":"11","key":"4414_CR24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048395","volume":"7","author":"DW Njomo","year":"2012","unstructured":"Njomo DW, et al. The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya. PLoS One. 2012;7(11):e48395.","journal-title":"PLoS One"},{"issue":"1","key":"4414_CR25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083413","volume":"9","author":"DW Njomo","year":"2014","unstructured":"Njomo DW, et al. Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya. PLoS One. 2014;9(1):e83413.","journal-title":"PLoS One"},{"key":"4414_CR26","volume-title":"Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes","author":"Organization, W.H","year":"2011","unstructured":"Organization, W.H., Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. 2011."},{"issue":"1","key":"4414_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12961-015-0005-z","volume":"13","author":"JC Moullin","year":"2015","unstructured":"Moullin JC, et al. A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework. Health Res Policy Syst. 2015;13(1):1.","journal-title":"Health Res Policy Syst"},{"issue":"2","key":"4414_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health Ment Health Serv Res. 2011;38(2):65\u201376.","journal-title":"Adm Policy Ment Health Ment Health Serv Res"},{"issue":"1","key":"4414_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-1","volume":"10","author":"J-A Atkinson","year":"2011","unstructured":"Atkinson J-A, et al. The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J. 2011;10(1):1.","journal-title":"Malar J"},{"issue":"4","key":"4414_CR30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"key":"4414_CR31","unstructured":"Law M, et al. Critical review form, qualitative studies. McMaster University. Grimmer K (2004): Incorporating health research methods and biostatistics and evidence-based research. Research Summer School (Ed.) Course Workbook University of South Australia. 1998."},{"issue":"1","key":"4414_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","volume":"8","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45.","journal-title":"BMC Med Res Methodol"},{"key":"4414_CR33","doi-asserted-by":"crossref","unstructured":"Bogus J, et al. Community attitudes toward mass drug administration for control and elimination of neglected tropical diseases after the 2014 outbreak of Ebola Virus Disease in Lofa County, Liberia. Am J Trop Med Hyg. 2016;94(3):497\u2013503.","DOI":"10.4269\/ajtmh.15-0591"},{"issue":"1","key":"4414_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00034983.2001.11813617","volume":"95","author":"M Gyapong","year":"2001","unstructured":"Gyapong M, Gyapong JO, Owusu-Banahene G. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Ann Trop Med Parasitol. 2001;95(1):77\u201386.","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"4414_CR35","first-page":"66","volume":"27","author":"DW Njomo","year":"2012","unstructured":"Njomo DW, et al. Factors associated with the motivation of community drug distributors in the Lymphatic Filariasis Elimination Programme in Kenya: original research. S Af J Epidemiol Infect. 2012;27(2):66\u201370.","journal-title":"S Af J Epidemiol Infect"},{"issue":"10","key":"4414_CR36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001346","volume":"5","author":"FO Richards","year":"2011","unstructured":"Richards FO, et al. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria. PLoS Negl Trop Dis. 2011;5(10):e1346.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"4414_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001574","volume":"6","author":"M Dembele","year":"2012","unstructured":"Dembele M, et al. Implementing preventive chemotherapy through an integrated National Neglected Tropical Disease Control Program in Mali. PLoS Negl Trop Dis. 2012;6(3):e1574.","journal-title":"PLoS Negl Trop Dis"},{"key":"4414_CR38","unstructured":"Offei M, Anto F. Compliance to mass drug administration programme for lymphatic filariasis elimination by community members and volunteers in the Ahanta West District of Ghana. J Bacteriol Parasitol. 2014:5(1)."},{"issue":"4","key":"4414_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002080","volume":"7","author":"YK Sodahlon","year":"2013","unstructured":"Sodahlon YK, et al. A success story: Togo is moving toward becoming the first sub-Saharan African nation to eliminate lymphatic filariasis through mass drug administration and countrywide morbidity alleviation. PLoS Negl Trop Dis. 2013;7(4):e2080.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"4414_CR40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pt.2006.05.010","volume":"22","author":"KA Mohammed","year":"2006","unstructured":"Mohammed KA, et al. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme. Trends Parasitol. 2006;22(7):340\u20134.","journal-title":"Trends Parasitol"},{"issue":"1\u20132","key":"4414_CR41","first-page":"69","volume":"13","author":"N Wamae","year":"2006","unstructured":"Wamae N, et al. Community-directed treatment of lymphatic filariasis in Kenya and its role in the national programmes for elimination of lymphatic filariasis. Afr J Health Sci. 2006;13(1\u20132):69\u201379.","journal-title":"Afr J Health Sci"},{"issue":"3","key":"4414_CR42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.2002.67.266","volume":"67","author":"DR Hopkins","year":"2002","unstructured":"Hopkins DR, et al. Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria. AmJTrop Med Hyg. 2002;67(3):266\u201372.","journal-title":"AmJTrop Med Hyg"},{"key":"4414_CR43","first-page":"10","volume":"4","author":"MN Malecela","year":"2009","unstructured":"Malecela MN, et al. Eliminating LF: a progress report from Tanzania. J Lymphoedema. 2009;4:10\u20132.","journal-title":"J Lymphoedema"},{"issue":"1","key":"4414_CR44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1017\/S0021932015000024","volume":"48","author":"WJ Kisoka","year":"2016","unstructured":"Kisoka WJ, et al. Community member's perceptions of mass drug administration for control of lymphatic filariasis in rural and urban Tanzania. J Biosoc Sci. 2016;48(1):94\u2013112.","journal-title":"J Biosoc Sci"},{"key":"4414_CR45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.socscimed.2013.11.036","volume":"102","author":"S Madon","year":"2014","unstructured":"Madon S, et al. Can mobile phones help control neglected tropical diseases? Experiences from Tanzania. Soc Sci Med. 2014;102:103\u201310.","journal-title":"Soc Sci Med"},{"issue":"6","key":"4414_CR46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003671","volume":"9","author":"PJ Hotez","year":"2015","unstructured":"Hotez PJ. Neglected Tropical Diseases in the Ebola-Affected Countries of West Africa. PLoS Negl Trop Dis. 2015;9(6):e0003671.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"4414_CR47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/her\/cyl116","volume":"22","author":"B Nandha","year":"2007","unstructured":"Nandha B, Krishnamoorthy K. School-based health education campaign\u2014a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis. Health Educ Res. 2007;22(4):539\u201346.","journal-title":"Health Educ Res"},{"issue":"8","key":"4414_CR48","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0277-9536(86)90241-8","volume":"22","author":"RM Garfield","year":"1986","unstructured":"Garfield RM, Vermund SH. Health education and community participation in mass drug administration for malaria in Nicaragua. Soc Sci Med. 1986;22(8):869\u201377.","journal-title":"Soc Sci Med"},{"issue":"4","key":"4414_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1179\/136485906X105598","volume":"100","author":"KD Ramaiah","year":"2006","unstructured":"Ramaiah KD, et al. A campaign of \u201ccommunication for behavioural impact\u201d to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol. 2006;100(4):345\u201361.","journal-title":"Ann Trop Med Parasitol"},{"key":"4414_CR50","volume-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","author":"A Krentel","year":"2013","unstructured":"Krentel, A., P.U. Fischer, and G.J. Weil, A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. 2013."},{"issue":"9708","key":"4414_CR51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(09)61749-9","volume":"375","author":"B Liese","year":"2010","unstructured":"Liese B, Rosenberg M, Schratz A. Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet. 2010;375(9708):67\u201376.","journal-title":"Lancet"},{"issue":"7","key":"4414_CR52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pt.2006.05.009","volume":"22","author":"PJ Lammie","year":"2006","unstructured":"Lammie PJ, Fenwick A, Utzinger J. A blueprint for success: integration of neglected tropical disease control programmes. Trends Parasitol. 2006;22(7):313\u201321.","journal-title":"Trends Parasitol"},{"issue":"8","key":"4414_CR53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2471\/BLT.06.029652","volume":"84","author":"FO Richards Jr","year":"2006","unstructured":"Richards FO Jr, et al. Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis. Bull World Health Organ. 2006;84(8):673\u20136.","journal-title":"Bull World Health Organ"},{"issue":"10","key":"4414_CR54","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pt.2007.08.007","volume":"23","author":"JH Kolaczinski","year":"2007","unstructured":"Kolaczinski JH, et al. Neglected tropical diseases in Uganda: the prospect and challenge of integrated control. Trends Parasitol. 2007;23(10):485\u201393.","journal-title":"Trends Parasitol"},{"issue":"sup1","key":"4414_CR55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/000349809X12502035776559","volume":"103","author":"A Hopkins","year":"2009","unstructured":"Hopkins A. Challenges for the integration of mass drug administrations against multiple\u2019neglected tropical diseases\u2019. Ann Trop Med Parasitol. 2009;103(sup1):23\u201331.","journal-title":"Ann Trop Med Parasitol"},{"issue":"4","key":"4414_CR56","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1365-3156.2003.01033.x","volume":"8","author":"I Sunish","year":"2003","unstructured":"Sunish I, et al. Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis. Tropical Med Int Health. 2003;8(4):316\u201321.","journal-title":"Tropical Med Int Health"},{"issue":"3","key":"4414_CR57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-3156.2008.02002.x","volume":"13","author":"C Huppatz","year":"2008","unstructured":"Huppatz C, et al. Eliminating lymphatic filariasis\u2013the surveillance challenge. Tropical Med Int Health. 2008;13(3):292\u20134.","journal-title":"Tropical Med Int Health"},{"issue":"suppl 4","key":"4414_CR58","doi-asserted-by":"crossref","first-page":"iv54","DOI":"10.1093\/heapol\/czs090","volume":"27","author":"RC Swanson","year":"2012","unstructured":"Swanson RC, et al. Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan. 2012;27(suppl 4):iv54\u201361.","journal-title":"Health Policy Plan"},{"issue":"1","key":"4414_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-14-1","volume":"14","author":"JM Zulu","year":"2014","unstructured":"Zulu JM, et al. Integrating national community-based health worker programmes into health systems: a systematic review identifying lessons learned from low-and middle-income countries. BMC Public Health. 2014;14(1):1.","journal-title":"BMC Public Health"},{"issue":"6","key":"4414_CR60","first-page":"717","volume":"78","author":"CJ Murray","year":"2000","unstructured":"Murray CJ, Frenk J. A framework for assessing the performance of health systems. Bull World Health Organ. 2000;78(6):717\u201331.","journal-title":"Bull World Health Organ"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-017-4414-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T22:47:42Z","timestamp":1569365262000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-017-4414-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4414"],"URL":"https:\/\/doi.org\/10.1186\/s12889-017-4414-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]},"article-number":"484"}}